Whole Food Diets

FDA: Pricey Drug Approved on Manipulated Data

fda

The FDA approved the gene therapy Zolgensma to treat children with a severe form of spinal muscular atrophy. The drug costs $2.125 million for a one-time treatment, CBS News reported.